Project Grant RM1NS128741
Award Date
9/22/22
Completion Date
8/31/25
Dollars Obligated
$14M
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Charlestown, MA 02129, USA
Similar Awards
The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an $11.2 million project grant to the University of Pittsburgh to define the mechanisms of pain relief associated with dorsal root ganglion and spinal cord stimulation. This three-year grant will support research under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to advance understanding of neuromodulatory devices for chronic pain treatment. The University will conduct preclinical...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $3,565,780 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a groundbreaking high frequency trans-spinal magnetic stimulation (HF-TSMS) system for the non-invasive treatment of neuropathic pain. The project aims to refine the HF-TSMS technology to target neural pathways involved in...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $6,522,833 Project Grant to The Leland Stanford Junior University to conduct a mechanistic randomized clinical trial investigating the central and peripheral nervous system mechanisms of pain relief induced by peripheral nerve stimulation (PNS) for the treatment of refractory chronic neuropathic pain. The 3-year study, funded under the NIH HEAL Initiative's CFDA 93.279 Drug Abuse and Addiction Research Programs, aims...
This $9,237,770 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a research program titled "IMPETUS: Integrated Mechanisms, Phenotypes, and Translational Underpinnings of Chronic Pain After Surgery". The goal is to gain integrated mechanistic insights into peripheral and central biological processes that contribute to chronic post-surgical pain (CPSP) and...
The National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), has awarded a $1,594,319 Cooperative Agreement to the University of Texas Health Science Center at Houston (UTHealth) to develop an integrated Breathing-Controlled Electrical Stimulation (BREESTIM) device and conduct a single-center randomized controlled clinical trial to examine the efficacy and safety of BREESTIM for managing neuropathic pain after spinal...
This $5,037,022 project grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke will support the development of novel single-cell technologies called "Raman2omics" to map pain-associated genes and cells across the lifespan. Funded under the Drug Abuse and Addiction Research Programs, the grant to the Massachusetts General Hospital aims to apply Raman2omics to systematically investigate genes and cells associated with postoperative pain...
This $242,061 Project Grant award from the National Institute of Neurological Disorders and Stroke, under the Drug Use and Addiction Research Programs (CFDA 93.279), establishes an interdisciplinary clinical pain research training program at Mass General Brigham in Boston. The program will support 8-12 postdoctoral fellows over 5 years, with the goal of expanding the pool of early-career investigators capable of launching successful clinical pain research careers. The program provides...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,314,276 to Emory University to develop and test novel methods for delivering and assessing nociceptive-specific (pain-specific) stimuli in both pain-free individuals and those with fibromyalgia. The project aims to overcome limitations in current experimental pain testing by identifying skin regions devoid of innocuous...
This $351,097 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) establishes an interdisciplinary clinical pain research training program at Mass General Brigham in Boston. The program will support 8-12 postdoctoral fellows over 5 years, providing protected research time, coursework, and mentorship to expand the pool of early-career clinical pain researchers. The training will focus on 8...
This $2,370,000 Project Grant, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop advanced human pluripotent stem cell (HPSC) tools for studying region-specific pain circuits. The key objectives are: 1) Developing scalable methods to generate region-specific sensory neurons and glial subtypes; 2) Creating and characterizing region-specific somatosensory organoids that mimic the in vivo...